Skip to main content
U.S. flag
Health and Human Services Logo

An official website of the Department of Health & Human Services

menu-iconMore mobile-close-icon
mobile-back-btn-icon Back
  • menu-iconMenu
  • mobile-search-icon
AHRQ: Agency for Healthcare Research and Quality
  • Search All AHRQ Sites
  • Careers
  • Contact Us
  • Español
  • FAQs
  • Email Updates
MEPS Home Medical Expenditure Panel Survey
Font Size:
Contact MEPS FAQ Site Map  
S
M
L
XL
 
 


Prescribed Drug Estimates: 2004

Table 1.1 Top Prescribed Drugs by Total Expenditures, 2004

Prescribed
drug name

Total
expenditures
ranking

Total
expenditures
Total number
of persons
with expenditures

Lipitor
1 9,227,876,454
15,040,075
Zocor
2 4,683,499,424
7,560,373
Nexium
3 4,158,497,404
5,059,004
Prevacid
4 3,389,672,495
5,514,370
Plavix
5 2,805,184,685
3,871,934
Advair
6 2,774,626,106
5,408,985
Norvasc
7 2,554,656,016
6,178,393
Zoloft
8 2,487,855,820
5,231,067
Celebrex
9 2,414,852,533
6,098,974
Lisinopril
10 2,147,873,809
8,955,191

Standard Errors for Table 1.1: Top Prescribed Drugs by Total Expenditures, 2004

Prescribed
drug name
Total
expenditures
Total number
of persons
with expenditures

Lipitor
448,055,618
588,287
Zocor
300,360,629
391,234
Nexium
394,391,389
321,363
Prevacid
247,667,162
288,532
Plavix
217,463,282
255,054
Advair
205,408,391
276,280
Norvasc
167,003,314
338,210
Zoloft
178,770,209
263,541
Celebrex
172,845,495
303,456
Lisinopril
165,625,151
516,377
 

 

MEPS HOME . CONTACT MEPS . MEPS FAQ . MEPS SITE MAP . MEPS PRIVACY POLICY . ACCESSIBILITY . VIEWERS & PLAYERS . COPYRIGHT
Back to topGo back to top
Back to Top Go back to top

Connect With Us

Facebook Twitter You Tube LinkedIn

Sign up for Email Updates

To sign up for updates or to access your subscriber preferences, please enter your email address below.

Agency for Healthcare Research and Quality

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364

  • Careers
  • Contact Us
  • Español
  • FAQs
  • Accessibility
  • Disclaimers
  • EEO
  • Electronic Policies
  • FOIA
  • HHS Digital Strategy
  • HHS Nondiscrimination Notice
  • Inspector General
  • Plain Writing Act
  • Privacy Policy
  • Viewers & Players
  • U.S. Department of Health & Human Services
  • The White House
  • USA.gov